MX2016003347A - Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes. - Google Patents

Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes.

Info

Publication number
MX2016003347A
MX2016003347A MX2016003347A MX2016003347A MX2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A
Authority
MX
Mexico
Prior art keywords
dimethylpropan
carboxy
ethyl
pharmaceutically acceptable
aminium
Prior art date
Application number
MX2016003347A
Other languages
English (en)
Other versions
MX368505B (es
Inventor
Ivars Kalvins
Ilmars Stonans
Maija Dambrova
Edgars Liepins
Helena Cirule
Ilga Misane
Elina Makarova
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of MX2016003347A publication Critical patent/MX2016003347A/es
Publication of MX368505B publication Critical patent/MX368505B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona con el uso de 3-Carboxi-N-etil-N,N-dimetilpropan-1-aminio y su sal farmacéuticamente aceptable para disminuir los niveles de plasma en sangre de insulina y glucosa.
MX2016003347A 2013-09-26 2014-09-15 Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes. MX368505B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13186201 2013-09-26
PCT/IB2014/064514 WO2015044828A1 (en) 2013-09-26 2014-09-15 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Publications (2)

Publication Number Publication Date
MX2016003347A true MX2016003347A (es) 2016-06-24
MX368505B MX368505B (es) 2019-10-04

Family

ID=49231372

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003347A MX368505B (es) 2013-09-26 2014-09-15 Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes.

Country Status (9)

Country Link
CN (1) CN105530929B (es)
AR (1) AR099638A1 (es)
BR (1) BR112016004211B1 (es)
CA (1) CA2924682C (es)
JO (1) JO3333B1 (es)
MX (1) MX368505B (es)
TN (1) TN2016000064A1 (es)
WO (1) WO2015044828A1 (es)
ZA (1) ZA201600894B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2067474A1 (en) * 2007-12-05 2009-06-10 Grindeks, a joint stock company Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate
LV14345B (lv) 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
ES2585558T3 (es) 2011-04-27 2016-10-06 Grindeks, A Joint Stock Company Uso de sales de 3-carboxi-N-etil-N,N-dimetilpropan-1-aminio en el tratamiento de una enfermedad cardiovascular

Also Published As

Publication number Publication date
CN105530929B (zh) 2018-03-02
BR112016004211B1 (pt) 2022-09-06
MX368505B (es) 2019-10-04
BR112016004211A2 (es) 2017-08-01
WO2015044828A1 (en) 2015-04-02
CA2924682C (en) 2018-02-27
AR099638A1 (es) 2016-08-10
TN2016000064A1 (en) 2017-07-05
CN105530929A (zh) 2016-04-27
ZA201600894B (en) 2017-05-31
JO3333B1 (ar) 2019-03-13
CA2924682A1 (en) 2015-04-02

Similar Documents

Publication Publication Date Title
PH12015500115B1 (en) Glucagon analogues
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
PH12015501088A1 (en) Dimeric compounds
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
HK1223529A1 (zh) 針對患有糖尿病的人的低血糖治療
MX2015012444A (es) Metodos de diagnostico, seleccion y tratamiento de enfermedades y afecciones provocadas por o asociadas con metanogenos.
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX2016003347A (es) Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes.
MX2017001737A (es) Vitamina b2 y sus usos.
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
MX351765B (es) Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares.
PT2699545T (pt) Novos derivados amino-pirrolínicos, sua utilização na prevenção e/ou tratamento do síndrome metabólico
PH12015500306A1 (en) Arry-520 for use in treating cancer in a patient with low aag
SG10201809418VA (en) New administration routes of insulin, insulin analogs or derivatives of insulin
刘欣 et al. How to Face the Difficulty in Our Life
PH12015500178B1 (en) Injectable supersaturated acetaminophen solution for spinal administration
UA55885U (ru) Способ коррекции повышенной агрегации тромбоцитов у больных гипертонической болезнью низкого и умеренного дополнительного риска
PL2852400T3 (pl) Analog insuliny lub jego farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna o przedłużonym działaniu terapeutycznym, zastosowanie analogu insuliny, sposób dawkowania oraz sposób leczenia cukrzycy
UA74052U (ru) Способ профилактики боковых грыж живота у больных с функционирующей колостомой и вентральной грыжей
UA79303U (ru) Применение таурина как средства стабилизации концентрации итраконазола в плазме крови при лечении грибковых заболеваний
AU2014903587A0 (en) Regulation of a blood glucose level in a patient with diabetes
UA74055U (ru) Способ хирургического лечения рефрактерных форм глаукомы

Legal Events

Date Code Title Description
FG Grant or registration